Emerging as a promising advance in the fight against obesity, the drug is attracting considerable attention . This treatment combines effects of two known GLP-1 receptor agonists, dulaglutide , plus an additional glucose-dependent hormonal component. Early study data have shown impressive fat decrease in people with obesity , possibly providing a e